Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Event Free Survival (EFS) Irrespective of Hematopoietic Cell Transplantation (HCT) Conditioning Regimen, Graft Αβ T and B-Cell Depletion or Patient Weight Category in Children with Acute Lymphoblastic Leukemia (ALL)
Hisham Abdel‐Azim(University of Southern California), Michael A. Pulsipher(Primary Children's Hospital), Eric Anderson(University of California San Diego), Mark C. Walters(UCSF Benioff Children's Hospital), Christopher C. Dvorak(University of California, San Francisco), Jemily Malvar(University of Southern California), Carrie L. Kitko(Vanderbilt University Medical Center), Dimitri Monos(Children's Hospital of Philadelphia), Sonali Chaudhury(Northwestern University), Julie‐An Talano(Dana-Farber Cancer Institute), Nancy Bunin(University of Iowa), Leung Wing(KK Women's and Children's Hospital), Mitchell S. Cairo(New York Medical College)
Cited by 1
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
|Journal of Clinical Oncology|2008|794
Common variants at five new loci associated with early-onset inflammatory bowel disease
|Nature Genetics|2009|483